APT Medical Inc. (SHA: 688617)
China flag China · Delayed Price · Currency is CNY
344.36
-0.84 (-0.24%)
Nov 13, 2024, 3:00 PM CST

APT Medical Income Statement

Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year
TTM FY 2023 FY 2022 FY 2021 FY 2020 FY 2019 2018 - 2017
Period Ending
Sep '24 Dec '23 Dec '22 Dec '21 Dec '20 Dec '19 2018 - 2017
Operating Revenue
1,9531,6421,204822.86477.94400.89
Upgrade
Other Revenue
8.498.4911.555.821.53.08
Upgrade
Revenue
1,9611,6501,216828.69479.44403.96
Upgrade
Revenue Growth (YoY)
27.16%35.71%46.74%72.85%18.68%67.08%
Upgrade
Cost of Revenue
555.18486.14354.04259.08142.13118.16
Upgrade
Gross Profit
1,4061,164861.98569.61337.3285.8
Upgrade
Selling, General & Admin
429.8386.96307.57251.43152.5122
Upgrade
Research & Development
272.46237.92174.88134.8871.970.42
Upgrade
Other Operating Expenses
19.614.5213.758.146.144.26
Upgrade
Operating Expenses
722.81639.21496.99393.93230.82197.77
Upgrade
Operating Income
683.34524.86364.99175.68106.4888.03
Upgrade
Interest Expense
-2.18-3.69-1.45-1.63-0.83-0.26
Upgrade
Interest & Investment Income
28.8427.7423.9413.261.210.68
Upgrade
Currency Exchange Gain (Loss)
2.662.661.17-1-0.43-0.39
Upgrade
Other Non Operating Income (Expenses)
-6.2-0.04-0.49-0.5-0.33-0.21
Upgrade
EBT Excluding Unusual Items
706.46551.53388.16185.81106.0987.85
Upgrade
Impairment of Goodwill
-3.84-3.84----
Upgrade
Gain (Loss) on Sale of Investments
-1.76-0.3421.72-0.07-1.01
Upgrade
Gain (Loss) on Sale of Assets
0.0511.970.060.02-0.23-0.08
Upgrade
Asset Writedown
-6.21-0.12-10.68-3.57--
Upgrade
Other Unusual Items
34.2936.8317.2517.5815.424.59
Upgrade
Pretax Income
728.98596.37395.13221.55121.2191.36
Upgrade
Income Tax Expense
81.3774.2454.9826.717.0213.28
Upgrade
Earnings From Continuing Operations
647.62522.13340.16194.85104.1978.08
Upgrade
Minority Interest in Earnings
11.2111.7917.8613.076.584.5
Upgrade
Net Income
658.82533.92358.02207.92110.7882.57
Upgrade
Net Income to Common
658.82533.92358.02207.92110.7882.57
Upgrade
Net Income Growth
31.58%49.13%72.19%87.70%34.15%283.85%
Upgrade
Shares Outstanding (Basic)
969696957273
Upgrade
Shares Outstanding (Diluted)
979898957273
Upgrade
Shares Change (YoY)
-0.33%-0.20%2.99%31.44%-0.29%0.09%
Upgrade
EPS (Basic)
6.835.543.712.201.531.14
Upgrade
EPS (Diluted)
6.765.463.662.191.531.14
Upgrade
EPS Growth
32.02%49.43%67.19%42.80%34.55%283.65%
Upgrade
Free Cash Flow
104.46487.03224.2514.01104.04-12.67
Upgrade
Free Cash Flow Per Share
1.074.982.290.151.44-0.17
Upgrade
Dividend Per Share
1.3791.3791.1380.6900.345-
Upgrade
Dividend Growth
21.21%21.21%64.98%100.03%--
Upgrade
Gross Margin
71.69%70.54%70.89%68.74%70.35%70.75%
Upgrade
Operating Margin
34.84%31.81%30.02%21.20%22.21%21.79%
Upgrade
Profit Margin
33.59%32.35%29.44%25.09%23.11%20.44%
Upgrade
Free Cash Flow Margin
5.33%29.51%18.44%1.69%21.70%-3.14%
Upgrade
EBITDA
749.44580.08405.69203.49126.49102.71
Upgrade
EBITDA Margin
38.21%35.15%33.36%24.56%26.38%25.43%
Upgrade
D&A For EBITDA
66.155.2240.727.812014.68
Upgrade
EBIT
683.34524.86364.99175.68106.4888.03
Upgrade
EBIT Margin
34.84%31.81%30.02%21.20%22.21%21.79%
Upgrade
Effective Tax Rate
11.16%12.45%13.91%12.05%14.04%14.54%
Upgrade
Revenue as Reported
1,9611,6501,216828.69479.44403.96
Upgrade
Source: S&P Capital IQ. Standard template. Financial Sources.